Hemoglobinopathies
Pharmacotherapies
Explore facts and recommendations for pharmacological treatments for hemoglobinopathies.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
HbF Induction
The Role of PKR Activation in Sickle Cell Disease
Sickle Cell Disease Clinical Development Programs
Information about various clinical trials (ASCENT1, HIBISCUS, GLADIOLUS, etc) to evaluate safety and efficacy for sickle cell disease and/or other hemoglobinopathies.
Find more information
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Continuing education
Learn about accredited hemoglobinopathies education opportunities supported by Novo Nordisk and provided by third-party organizations.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
